The French medical biology market is worth over €5 billion. In 2020 , the market for medical biology laboratories boomed as a result of the COVID-19 pandemic, leading to a significant increase in demand for PCR tests and antigens. Between May 2020 and the end of 2022, laboratories performed around 120 million Covid PCR tests, contributing around 25% of their sales. Sales are down on the peak years of the pandemic, but remain well above pre-pandemic baseline levels. The market is undergoing major restructuring, with a considerable reduction in the number of laboratories as a result of mergers and acquisitions. 4,200 biology sites are controlled by 400 laboratories in France, the number of which has been divided by 10 in a decade . Although the number of laboratories has fallen, employment has remained relatively stable. The market is mainly operated by large groups such as Biogroup, Cerba and Inovie, which have a combined market share of 40%. Despite market consolidation, independent la
